What is an IHHT system?

IHHT stands for Intermittent Hypoxic-Hyperoxic Training. An IHHT system is equipment that alternates the air a person breathes between a reduced-oxygen mixture (roughly 10–12% O₂) and an oxygen-enriched mixture (roughly 60–75% O₂) through a sealed mask, with real-time SpO₂ and heart rate monitoring.

Where is the Mito2 IHHT system manufactured?

Mito2 is designed, assembled, and supported by Ergo Flex Technologies in Conroe, Texas. The platform has been continuously engineered by the same in-house team since 2018.

Is the Mito2 hardware patented?

Yes. The oxygen delivery hardware is protected by US Patent No. 10,894,139, granted January 19, 2021. The patent covers device design only and is not a medical claim, endorsement, or certification of any treatment or health outcome.

What safety monitoring is built in?

Every session is monitored on a 15.6-inch HD touchscreen with continuous SpO₂ and heart rate tracking. A safety floor at 80% SpO₂ automatically switches the client to enriched-oxygen air if that threshold is reached.

How long is a typical IHHT session?

Sessions range from 28 to 47 minutes depending on the protocol phase: Adaptive (4 cycles, ~28–35 min), Conditioning (5 cycles, ~35–40 min), and Optimized (6 cycles, ~42–47 min).

Is Mito2 a medical device?

No. Mito2 is intended for general wellness and relaxation purposes only. It is not intended to diagnose, treat, cure, or prevent any disease.

What Mito2 is

Mito2 is a turnkey IHHT platform built for wellness facilities including medical spas, chiropractic facilities, integrative medical practices, performance gyms, trainers, and wellness centers. A single technician can run safe, fully programmed 40 to 50 minute sessions on standard 110V power.

Each session alternates short intervals of low-oxygen air with higher-oxygen air, recreating the cellular signal of training at altitude without leaving the facility. The mechanism is rooted in the HIF-1 alpha oxygen-sensing pathway recognized by the 2019 Nobel Prize in Physiology or Medicine. Mito2 is a wellness modality, not a treatment for any medical condition.

Why facilities add Mito2

Turnkey simulated altitude therapy equipment for wellness facilities.

Real-time SpO2 monitoring with an 80 percent SpO2 safety floor.

Five training modes: Adaptive, Conditioning, Optimized, Custom, and EWOT.

Designed, engineered, and supported in the USA by Ergo Flex Technologies in Conroe, Texas.

CAT (Certified Altitude Technician) credential program through O2 Pro Academy: 13 modules and 57 lessons.

Essentials Kit included: Personal O2 Mask, Filter, Squeeze ball, Backpack, and Strap.

Optional Oasis Lounger (Full Body Relax) zero-gravity seating for elevated client experience.

Built by Engineers. Backed by a US Patent.

Mito2 is the work of an in-house engineering and product research team that has been refining Responsive Oxygen Training equipment in Conroe, Texas since 2018.

Mito2 IHHT Systems, Designed and Manufactured in the USA

Mito2 builds IHHT systems (Intermittent Hypoxic-Hyperoxic Training equipment) for wellness facilities across North America. Every system is designed, assembled, and supported by our in-house team in Conroe, Texas, with continuous engineering work on the platform since 2018. Our oxygen delivery hardware is protected by US Patent 10,894,139, granted January 19, 2021.

American Manufacturing

Every unit is built by Ergo Flex Technologies in Conroe, Texas. Not imported, not white-labeled.

In-House R&D Since 2018

The same team that designed Mito2 still engineers, tests, and supports it today.

US Patent Granted

Our oxygen delivery hardware is protected by US Patent 10,894,139, granted January 19, 2021.

US Patent Granted, 2021

Patented Oxygen Delivery Device

In January 2021, the United States Patent and Trademark Office granted Patent No. 10,894,139 to inventor J. T. Anderson for the oxygen delivery hardware that powers Mito2.

Protected engineering, built in America, refined continuously by the same team that originated the design.

Patent No.: 10,894,139
Granted: January 19, 2021

United States Patent certificate, granted January 19, 2021, Patent No. 10,894,139, Oxygen Delivery Device, inventor J. T. Anderson

Patent Disclaimer: US Patent No. 10,894,139 protects the design of the oxygen delivery device hardware only. The patent is not a medical claim, endorsement, certification, or approval of any treatment, therapy, diagnosis, or health outcome by the United States Patent and Trademark Office, the FDA, or any other regulatory body. Mito2 is intended for general wellness and relaxation purposes only and is not a medical device. It is not intended to diagnose, treat, cure, or prevent any disease.

IHHT System FAQ

Common Questions About the Mito2 IHHT System

Verifiable answers about how the system is built, where it is made, and how it operates.

Simulated Altitude Therapy Equipment for Wellness Facilities